![]() |
市场调查报告书
商品编码
1552368
静脉导管(IV 导管)市场:成长、未来前景、竞争分析,2024-2032 年Intravenous Catheters Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032 |
静脉导管(IV 导管)是一种医疗器械,旨在将药物、液体和营养物质直接输送到患者的静脉系统中或收集血液样本以进行测试。这些导管在各种治疗和手术中发挥重要作用,并已成为医院和诊所等医疗环境中的主要产品。预计 2024 年至 2032 年,静脉导管市场将以 6.1% 的复合年增长率成长。
在慢性病盛行率不断上升、手术数量不断增加以及医疗技术进步的推动下,静脉导管市场正在稳步增长。此外,世界人口老化,更容易患上需要静脉治疗的慢性疾病,如心血管疾病、癌症和糖尿病,也大大增加了静脉导管的需求。此外,更复杂的导管技术的发展,包括旨在降低针刺伤害和感染风险的安全导管,正在提高静脉治疗的效率和安全性。从区域来看,市场分为北美、欧洲、亚太地区和世界其他地区。由于先进的医疗基础设施、高昂的医疗成本和主要的市场参与者,北美占有重要的市场份额。然而,由于卫生设施的改善、医疗意识的提高以及慢性病盛行率的上升,亚太地区正在经历快速增长。
慢性病盛行率上升是驱动因素
全球慢性病盛行率的上昇在很大程度上推动了静脉导管市场的成长。静脉导管在糖尿病、癌症和心血管疾病等慢性疾病中发挥着至关重要的作用,这些疾病通常需要长期药物、水合和营养支持。根据世界卫生组织 (WHO) 的数据,慢性病是全世界死亡的主要原因,占所有死亡的 71%。慢性健康状况日益加重的负担增加了对静脉导管的需求。这是因为静脉导管对于治疗和有效管理这些疾病至关重要。例如,在癌症治疗的化疗中,中心静脉导管对于长时间输送药物至关重要。
科技进步的机会
由于技术进步,静脉导管市场拥有庞大的商机。旨在降低针刺伤害和血液感染风险的安全静脉导管等创新技术越来越多地在医疗环境中被采用。另一个主要商机是开发抗菌导管,有助于减少导管相关感染。这些进步正在受到世界各地的医院和诊所的欢迎,因为它们不仅提高了患者的安全,而且提高了医疗程序的效率。
静脉导管的成本和维护是限制因素
然而,由于静脉导管的成本和维护,市场面临限制。高品质导管,尤其是具有先进安全功能的导管,可能很昂贵,这构成了挑战,特别是对于医疗预算有限的发展中国家的医疗机构而言。此外,静脉导管的维护和正确处理需要训练有素的医疗专业人员,这会增加营运成本并阻碍资源有限环境中的市场成长。
导管相关併发症的挑战
静脉导管市场的主要挑战之一是感染和血栓形成等导管相关併发症的管理。导管相关血流感染 (CRBSI) 是一个严重的问题,会导致发病率增加、住院时间延长和医疗费用增加。儘管导管技术取得了进步,但这些併发症的风险仍然是一个重大问题,需要继续研究和开发以改善导管设计和使用方案。挑战在于平衡有效静脉通路的需求与尽量减少长期使用导管相关的风险。
市场区隔:按类型
静脉导管市场按类型分为外周导管、中线外周导管和中心静脉导管,每种都满足特定的临床需求。週边导管通常用于短期给药,广泛应用于各种医疗环境中的即时静脉通路,引领市场收入。它的受欢迎是由于它在急性护理中的常规使用,从输液治疗到药物管理。中心静脉导管设计用于长期使用,例如化疗和全肠外营养治疗,预计具有最高的复合年增长率(CAGR)。
静脉导管市场
这种增长是由于需要长期治疗的慢性疾病的盛行率不断上升以及复杂治疗中对中心静脉导管的日益偏好所推动的。中线外周导管作为外周静脉导管和中心静脉导管之间的中间导管,由于其在中期静脉治疗中的用途而越来越受欢迎。
区域洞察
静脉导管市场的区域市场分析观察到不同的区域趋势和成长潜力。 2023年,受先进医疗基础设施、高医疗成本以及广泛采用先进医疗技术等因素影响,北美地区销售额占最高值。该地区的市场主导地位也受到慢性病的高盛行率以及对静脉导管插入治疗和药物输送的相关需求的推动。然而,预计2024年至2032年亚太地区的复合年增长率(CAGR)最高。这一预期成长的推动因素包括医疗保健成本上升、先进医学意识增强以及中国和印度等新兴国家需要静脉治疗的疾病盛行率不断上升。此外,政府改善医疗基础设施的措施以及这些地区主要市场参与者的增加也促进了这一成长轨迹。
竞争趋势
就竞争趋势和策略而言,静脉导管市场包含不同的参与者和方法。到 2023 年,Becton、Dickinson and Company (BD)、B. Braun Melsungen AG、Terumo Corporation、Mediplus India Ltd、Sterimed Group、Medilivescare Manufacturing Pvt. Ltd、Angiplast Pvt Ltd、Teleflex Incorporated、Nipro Europe Group Companies 等主要公司库克、ICU Medical, Inc.、TuCann Medical 等公司为市场收入做出了贡献。这些公司传统上专注于创新和扩张策略以维持其市场地位。
本报告回答的主要问题
影响静脉导管市场成长的关键微观和宏观环境因素有哪些?
在目前和预测期间内,产品领域和地区的主要投资领域是什么?
2032 年之前的预估与市场预测
哪个细分市场在预测期间内复合年增长率最快?
哪个细分市场拥有较大的市场份额,为什么?
低收入和中等收入国家是否投资静脉导管市场?
静脉导管市场最大的区域市场是哪一个?
亚太地区、拉丁美洲和中东/非洲等新兴市场的市场趋势和动态是什么?
推动静脉导管市场成长的主要趋势是什么?
主要竞争对手是什么?
Intravenous (IV) catheters are medical devices designed for delivering medications, fluids, and nutrients directly into a patient's venous system and for drawing blood samples for testing purposes. These catheters play a critical role in a wide range of medical treatments and procedures, making them a staple in hospitals, clinics, and other healthcare settings. The intravenous catheters market is growing is estimated to grow at a CAGR of 6.1% from 2024 to 2032.
The market for intravenous catheters has witnessed steady growth, driven by the increasing prevalence of chronic diseases, the rising number of surgical procedures, and advancements in medical technology. The aging global population, which is more prone to chronic conditions requiring IV therapy, such as cardiovascular diseases, cancer, and diabetes, also significantly contributes to the demand for IV catheters. Furthermore, the development of more sophisticated catheter technologies, including safety catheters designed to reduce the risk of needlestick injuries and infections, has enhanced the efficiency and safety of intravenous therapy. Geographically, the market is segmented across North America, Europe, Asia-Pacific, and other regions. North America holds a significant share of the market, attributed to its advanced healthcare infrastructure, high healthcare spending, and the presence of key market players. However, the Asia-Pacific region is witnessing rapid growth due to improving healthcare facilities, increasing healthcare awareness, and the rising prevalence of chronic diseases.
Increasing Prevalence of Chronic Diseases as a Driver
The growth of the intravenous (IV) catheters market is significantly propelled by the rising prevalence of chronic diseases worldwide. Chronic conditions such as diabetes, cancer, and cardiovascular diseases often necessitate long-term medication administration, hydration, and nutrition, where IV catheters play a pivotal role. According to the World Health Organization (WHO), chronic diseases are the leading cause of mortality globally, accounting for 71% of all deaths. This escalation in chronic health conditions increases the demand for IV catheters, as they are essential for administering treatments and managing these diseases effectively. For example, in chemotherapy for cancer treatment, central venous catheters are indispensable for delivering drugs over an extended period.
Opportunity in Technological Advancements
The IV catheters market presents substantial opportunities through technological advancements. Innovations such as safety IV catheters, designed to reduce needlestick injuries and the risk of bloodstream infections, are increasingly being adopted in healthcare settings. The development of antimicrobial catheters, which help in reducing catheter-related infections, also represents a significant opportunity. These advancements not only improve patient safety but also enhance the efficiency of medical procedures, leading to their growing acceptance in hospitals and clinics worldwide.
Cost and Maintenance of IV Catheters as a Restraint
However, the market faces restraints due to the cost and maintenance associated with IV catheters. High-quality catheters, particularly those with advanced safety features, can be expensive, posing a challenge for healthcare facilities, especially in developing countries with limited healthcare budgets. Furthermore, the maintenance and proper handling of IV catheters, requiring trained healthcare professionals, add to the operational costs, thus hindering the market's growth in resource-constrained settings.
Challenge of Catheter-Related Complications
One significant challenge in the IV catheters market is managing catheter-related complications, such as infections and thrombosis. Catheter-related bloodstream infections (CRBSIs) are a serious concern, leading to increased morbidity, extended hospital stays, and higher healthcare costs. Despite advancements in catheter technology, the risk of these complications remains a critical issue, necessitating ongoing research and development to improve catheter designs and usage protocols. The challenge lies in balancing the need for effective intravenous access with minimizing the risks associated with long-term catheter use.
Market Segmentation by Type
The intravenous (IV) catheters market is segmented by type into peripheral catheters, midline peripheral catheters, and central venous catheters, each serving specific clinical needs. Peripheral catheters, commonly used for short-term medication administration, lead in market revenue due to their widespread use in various medical settings for immediate venous access. Their prevalence is attributed to the routine nature of their applications, ranging from fluid therapy to medication delivery in acute care. Central venous catheters, designed for long-term use, such as in chemotherapy or total parenteral nutrition, are anticipated to register the highest Compound Annual Growth Rate (CAGR).
The intravenous (IV) catheters market
This growth is driven by the increasing prevalence of chronic diseases requiring prolonged treatments and the growing preference for central venous catheters in complex medical treatments. Midline peripheral catheters, serving as a middle ground between peripheral and central venous catheters, are also gaining popularity for their utility in medium-term intravenous therapy.
Regional Insights
In the geographic analysis of the intravenous (IV) catheters market, distinct regional trends and growth potentials are observed. In 2023, North America held the highest revenue percentage, a position influenced by factors like advanced healthcare infrastructure, high healthcare expenditure, and the prevalent use of advanced medical technologies. The region's market dominance was also supported by the high incidence of chronic diseases and the consequent need for IV catheterization for treatment and drug administration. However, looking ahead from 2024 to 2032, the Asia-Pacific region is expected to experience the highest Compound Annual Growth Rate (CAGR). This anticipated growth is attributed to the increasing healthcare expenditures, rising awareness of advanced medical treatments, and the growing prevalence of diseases requiring IV therapy in emerging economies such as China and India. Additionally, government initiatives to improve healthcare infrastructure and the expanding presence of key market players in these regions contribute to this growth trajectory.
Competitive trends
In terms of competitive trends and strategies, the IV catheters market encompasses a diverse array of players and approaches. In 2023, leading companies like Becton, Dickinson and Company (BD), B. Braun Melsungen AG, and Terumo Corporation, Mediplus India Ltd, Sterimed Group, Medilivescare Manufacturing Pvt. Ltd., Angiplast Pvt Ltd., Teleflex Incorporated, Nipro Europe Group Companies, Cook, ICU Medical, Inc., and TuCann Medical were notable contributors to the market's revenue. These companies have historically focused on innovation and expansion strategies to maintain their market positions. For instance, BD's emphasis on developing safety IV catheters and B. Braun's focus on user-friendly catheter designs have set them apart in the market. Terumo Corporation has also made significant strides, particularly in expanding its product range and geographic reach. From 2024 to 2032, these companies, along with emerging players, are expected to continue focusing on strategic collaborations, mergers, and acquisitions to enhance their market presence. The market is also likely to witness increased investment in research and development to introduce more advanced and patient-friendly IV catheter products. This competitive landscape highlights the dynamic and innovative nature of the IV catheters market, where evolving healthcare needs and technological advancements drive growth and strategic shifts among key players.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Intravenous Catheters market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Intravenous Catheters market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Type
End-Use
Region Segment (2022-2032; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Intravenous Catheters market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Intravenous Catheters market?
Which is the largest regional market for Intravenous Catheters market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Intravenous Catheters market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Intravenous Catheters market worldwide?
FIG. 9Market Positioning of Key Intravenous Catheters Market Players, 2023
FIG. 10Global Intravenous Catheters Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032